The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.

Abstract

A B S T R A C T Studies were carried out in a family in which two children with cholestasis due to intrahepatic bile duct anomalies were shown to have increased amounts of the cholic acid precursor, 3a,7a, 12a-trihydroxy-5P-cholestan-26-oic acid (THCA). The metabolism of THCA was studied in one of these patients after an intravenous injection of [8H]THCA, and the cause of the increased amounts of THCA in this condition was found to be due to a metabolic defect in the conversion of this compound into cholic acid. A small amount of ['H]cholic acid was also identified after [3H]THCA administration, confirming that this metabolic defect was incomplete. Varanic acid (3a,7a,12a, 24t-tetrahydroxy-5fi-cholestan-26-oic acid), a metabolite of THCA, could not be identified in either of these patients. By assuming that this compound would be conjugated and excreted if the metabolic block occurred after the formation of varanic acid, the defect in these patients appears to be due to a deficiency of a 24-hydroxylating enzyme system required to convert THCA into varanic acid.This condition appears to be transmitted in an autosomal recessive fashion, because the two affected patients were of opposite sex, and neither a normal Presented in abstract form at the annual meeting of the American

Postnatal physiologic hypercholemia in both premature and full-term infants.

“…C27 bile salts, previously found in certain cholestasis syndromes (39,40), were essentially absent suggesting that the enzymes involved in the oxidative cleavage of the terminal three carbons of the side chain are present in adequate quantities at this stage of fetal development. No evidence was obtained for the presence of C20 and C21 bile acids, recently found in meconium (41).…”

Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids.

“…The inborn errors ofbile acid synthesis described to date all affect side-chain oxidation (2)(3)(4)(5)(6)(7)(8), eg., cerebrotendinous xanthomatosis (2-5), Zellweger syndrome, infantile Refsum's disease, neonatal adrenoleukodystrophy (2,6), and pseudo-Zellweger syndrome (7).…”

Bile acid synthesis in man. In vivo activity of the 25-hydroxylation pathway.

“…Enzyme systems necessary for both pathways have been identified in rat and human liver (3,5,6). Moreover, intermediates exclusive to each pathway have been identified in bile of normal human subjects (7,8).…”